A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.

Autor: Büttner, Florian A.1,2 (AUTHOR), Winter, Stefan1,2 (AUTHOR), Stühler, Viktoria3 (AUTHOR), Rausch, Steffen3 (AUTHOR), Hennenlotter, Jörg3 (AUTHOR), Füssel, Susanne4 (AUTHOR), Zastrow, Stefan4 (AUTHOR), Meinhardt, Matthias5 (AUTHOR), Toma, Marieta5,6 (AUTHOR), Jerónimo, Carmen7,8,9 (AUTHOR), Henrique, Rui7,8,9 (AUTHOR), Miranda-Gonçalves, Vera7,8,9 (AUTHOR), Kröger, Nils10 (AUTHOR), Ribback, Silvia11 (AUTHOR), Hartmann, Arndt12 (AUTHOR), Agaimy, Abbas12 (AUTHOR), Stöhr, Christine12 (AUTHOR), Polifka, Iris12 (AUTHOR), Fend, Falko13 (AUTHOR), Scharpf, Marcus13 (AUTHOR)
Zdroj: Genome Medicine. 9/15/2022, Vol. 14 Issue 1, p1-19. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje